Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Timing in Cesarean Section
NCT03246919Phase 4Terminated
- Sponsor
- Loyola University Chicago
- Start
- Sep 2017
- Primary completion
- Feb 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Loyola University Chicago. Primary endpoint: Total blood loss. Started Sep 2017; status: terminated.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03246919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03246919.